Skip to main content
Erschienen in: European Radiology 10/2010

01.10.2010 | Hepatobiliary-Pancreas

Outcomes of follow-up CT for small (5–10-mm) arterially enhancing nodules in the liver and risk factors for developing hepatocellular carcinoma in a surveillance population

verfasst von: Min Jung Park, Young-sun Kim, Won Jae Lee, Hyo K. Lim, Hyunchul Rhim, Jongmee Lee

Erschienen in: European Radiology | Ausgabe 10/2010

Einloggen, um Zugang zu erhalten

Abstract

Objective:

To evaluate the outcomes of small (5–10 mm), arterially enhancing nodules (SAENs) shown exclusively at the hepatic arterial phase of CT in a hepatocellular carcinoma (HCC) surveillance population and to determine risk factors for developing HCC.

Methods:

The study population included 112 patients (male:female = 100:12; aged 36–92 years) with 175 SAENs who were at risk of HCC. We evaluated serial changes during follow-up (1.4–41.8 months, mean 35.7 months) and analysed the initial CT findings of SAENs and the accompanying lesions to elucidate the risk factors for HCC development.

Results:

Of 175 SAENs, 101(57.7%) disappeared and 34(19.4%) persisted. Forty SAENs (22.9%) became HCC in 33 patients (29.5%). Presence of HCC treatment history (p = 0.005, risk ratio = 7.429), a larger size of SAEN (p = 0.003, risk ratio = 1.630), presence of coexistent HCC (p = 0.021, risk ratio = 3.777) and absence of coexistent typical arterioportal shunts (p = 0.003, risk ratio = 4.459) turned out to be independently significant risk factors for future development of HCC.

Conclusion:

SAENs were frequently seen in an HCC surveillance population and have a 22.9% probability of becoming HCC on a per-lesion basis. Risk increased particularly when the lesion was associated with a previous or concurrent HCC, a large size or found without a coexistent typical arterioportal shunt.
Literatur
1.
Zurück zum Zitat Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christensen E, Pagliaro L, Colombo M, Rodes J (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35:421–430CrossRefPubMed Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christensen E, Pagliaro L, Colombo M, Rodes J (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35:421–430CrossRefPubMed
2.
Zurück zum Zitat Nzeako UC, Goodman ZD, Ishak KG (1996) Hepatocellular carcinoma in cirrhotic and noncirrhotic livers. A clinico-histopathologic study of 804 North American patients. Am J Clin Pathol 105:65–75PubMed Nzeako UC, Goodman ZD, Ishak KG (1996) Hepatocellular carcinoma in cirrhotic and noncirrhotic livers. A clinico-histopathologic study of 804 North American patients. Am J Clin Pathol 105:65–75PubMed
3.
Zurück zum Zitat Bennett GL, Krinsky GA, Abitbol RJ, Kim SY, Theise ND, Teperman LW (2002) Sonographic detection of hepatocellular carcinoma and dysplastic nodules in cirrhosis: correlation of pretransplantation sonography and liver explant pathology in 200 patients. AJR Am J Roentgenol 179:75–80PubMed Bennett GL, Krinsky GA, Abitbol RJ, Kim SY, Theise ND, Teperman LW (2002) Sonographic detection of hepatocellular carcinoma and dysplastic nodules in cirrhosis: correlation of pretransplantation sonography and liver explant pathology in 200 patients. AJR Am J Roentgenol 179:75–80PubMed
4.
Zurück zum Zitat Libbrecht L, Bielen D, Verslype C, Vanbeckevoort D, Pirenne J, Nevens F, Desmet V, Roskams T (2002) Focal lesions in cirrhotic explant livers: pathological evaluation and accuracy of pretransplantation imaging examinations. Liver Transpl 8:749–761CrossRefPubMed Libbrecht L, Bielen D, Verslype C, Vanbeckevoort D, Pirenne J, Nevens F, Desmet V, Roskams T (2002) Focal lesions in cirrhotic explant livers: pathological evaluation and accuracy of pretransplantation imaging examinations. Liver Transpl 8:749–761CrossRefPubMed
5.
Zurück zum Zitat Rode A, Bancel B, Douek P, Chevallier M, Vilgrain V, Picaud G, Henry L, Berger F, Bizollon T, Gaudin JL, Ducerf C (2001) Small nodule detection in cirrhotic livers: evaluation with US, spiral CT, and MRI and correlation with pathologic examination of explanted liver. J Comput Assist Tomogr 25:327–336CrossRefPubMed Rode A, Bancel B, Douek P, Chevallier M, Vilgrain V, Picaud G, Henry L, Berger F, Bizollon T, Gaudin JL, Ducerf C (2001) Small nodule detection in cirrhotic livers: evaluation with US, spiral CT, and MRI and correlation with pathologic examination of explanted liver. J Comput Assist Tomogr 25:327–336CrossRefPubMed
6.
Zurück zum Zitat Baron RL, Peterson MS (2001) From the RSNA refresher courses: screening the cirrhotic liver for hepatocellular carcinoma with CT and MR imaging: opportunities and pitfalls. Radiographics 21 Spec No:S117–132 Baron RL, Peterson MS (2001) From the RSNA refresher courses: screening the cirrhotic liver for hepatocellular carcinoma with CT and MR imaging: opportunities and pitfalls. Radiographics 21 Spec No:S117–132
7.
Zurück zum Zitat Brancatelli G, Baron RL, Peterson MS, Marsh W (2003) Helical CT screening for hepatocellular carcinoma in patients with cirrhosis: frequency and causes of false-positive interpretation. AJR Am J Roentgenol 180:1007–1014PubMed Brancatelli G, Baron RL, Peterson MS, Marsh W (2003) Helical CT screening for hepatocellular carcinoma in patients with cirrhosis: frequency and causes of false-positive interpretation. AJR Am J Roentgenol 180:1007–1014PubMed
8.
Zurück zum Zitat Federle MP (2002) Use of radiologic techniques to screen for hepatocellular carcinoma. J Clin Gastroenterol 35:S92–S100CrossRefPubMed Federle MP (2002) Use of radiologic techniques to screen for hepatocellular carcinoma. J Clin Gastroenterol 35:S92–S100CrossRefPubMed
9.
Zurück zum Zitat Lee KH, O’Malley ME, Haider MA, Hanbidge A (2004) Triple-phase MDCT of hepatocellular carcinoma. AJR Am J Roentgenol 182:643–649PubMed Lee KH, O’Malley ME, Haider MA, Hanbidge A (2004) Triple-phase MDCT of hepatocellular carcinoma. AJR Am J Roentgenol 182:643–649PubMed
10.
Zurück zum Zitat Loyer EM, Chin H, DuBrow RA, David CL, Eftekhari F, Charnsangavej C (1999) Hepatocellular carcinoma and intrahepatic peripheral cholangiocarcinoma: enhancement patterns with quadruple phase helical CT–a comparative study. Radiology 212:866–875PubMed Loyer EM, Chin H, DuBrow RA, David CL, Eftekhari F, Charnsangavej C (1999) Hepatocellular carcinoma and intrahepatic peripheral cholangiocarcinoma: enhancement patterns with quadruple phase helical CT–a comparative study. Radiology 212:866–875PubMed
11.
Zurück zum Zitat Murakami T, Kim T, Takamura M, Hori M, Takahashi S, Federle MP, Tsuda K, Osuga K, Kawata S, Nakamura H, Kudo M (2001) Hypervascular hepatocellular carcinoma: detection with double arterial phase multi-detector row helical CT. Radiology 218:763–767PubMed Murakami T, Kim T, Takamura M, Hori M, Takahashi S, Federle MP, Tsuda K, Osuga K, Kawata S, Nakamura H, Kudo M (2001) Hypervascular hepatocellular carcinoma: detection with double arterial phase multi-detector row helical CT. Radiology 218:763–767PubMed
12.
Zurück zum Zitat Freeny PC, Grossholz M, Kaakaji K, Schmiedl UP (2003) Significance of hyperattenuating and contrast-enhancing hepatic nodules detected in the cirrhotic liver during arterial phase helical CT in pre-liver transplant patients: radiologic-histopathologic correlation of explanted livers. Abdom Imaging 28:333–346CrossRefPubMed Freeny PC, Grossholz M, Kaakaji K, Schmiedl UP (2003) Significance of hyperattenuating and contrast-enhancing hepatic nodules detected in the cirrhotic liver during arterial phase helical CT in pre-liver transplant patients: radiologic-histopathologic correlation of explanted livers. Abdom Imaging 28:333–346CrossRefPubMed
13.
Zurück zum Zitat Holland AE, Hecht EM, Hahn WY, Kim DC, Babb JS, Lee VS, West AB, Krinsky GA (2005) Importance of small (< or = 20-mm) enhancing lesions seen only during the hepatic arterial phase at MR imaging of the cirrhotic liver: evaluation and comparison with whole explanted liver. Radiology 237:938–944CrossRefPubMed Holland AE, Hecht EM, Hahn WY, Kim DC, Babb JS, Lee VS, West AB, Krinsky GA (2005) Importance of small (< or = 20-mm) enhancing lesions seen only during the hepatic arterial phase at MR imaging of the cirrhotic liver: evaluation and comparison with whole explanted liver. Radiology 237:938–944CrossRefPubMed
14.
Zurück zum Zitat Choi BI, Lee KH, Han JK, Lee JM (2002) Hepatic arterioportal shunts: dynamic CT and MR features. Korean J Radiol 3:1–15CrossRefPubMed Choi BI, Lee KH, Han JK, Lee JM (2002) Hepatic arterioportal shunts: dynamic CT and MR features. Korean J Radiol 3:1–15CrossRefPubMed
15.
Zurück zum Zitat Byrnes V, Shi H, Kiryu S, Rofsky NM, Afdhal NH (2007) The clinical outcome of small (<20 mm) arterially enhancing nodules on MRI in the cirrhotic liver. Am J Gastroenterol 102:1654–1659CrossRefPubMed Byrnes V, Shi H, Kiryu S, Rofsky NM, Afdhal NH (2007) The clinical outcome of small (<20 mm) arterially enhancing nodules on MRI in the cirrhotic liver. Am J Gastroenterol 102:1654–1659CrossRefPubMed
16.
Zurück zum Zitat Hwang SH, Yu JS, Kim KW, Kim JH, Chung JJ (2008) Small hypervascular enhancing lesions on arterial phase images of multiphase dynamic computed tomography in cirrhotic liver: fate and implications. J Comput Assist Tomogr 32:39–45CrossRefPubMed Hwang SH, Yu JS, Kim KW, Kim JH, Chung JJ (2008) Small hypervascular enhancing lesions on arterial phase images of multiphase dynamic computed tomography in cirrhotic liver: fate and implications. J Comput Assist Tomogr 32:39–45CrossRefPubMed
17.
Zurück zum Zitat O’Malley ME, Takayama Y, Sherman M (2005) Outcome of small (10–20 mm) arterial phase-enhancing nodules seen on triphasic liver CT in patients with cirrhosis or chronic liver disease. Am J Gastroenterol 100:1523–1528CrossRefPubMed O’Malley ME, Takayama Y, Sherman M (2005) Outcome of small (10–20 mm) arterial phase-enhancing nodules seen on triphasic liver CT in patients with cirrhosis or chronic liver disease. Am J Gastroenterol 100:1523–1528CrossRefPubMed
18.
19.
Zurück zum Zitat Sultana S, Awai K, Nakayama Y, Nakaura T, Liu D, Hatemura M, Funama Y, Morishita S, Yamashita Y (2007) Hypervascular hepatocellular carcinomas: bolus tracking with a 40-detector CT scanner to time arterial phase imaging. Radiology 243:140–147CrossRefPubMed Sultana S, Awai K, Nakayama Y, Nakaura T, Liu D, Hatemura M, Funama Y, Morishita S, Yamashita Y (2007) Hypervascular hepatocellular carcinomas: bolus tracking with a 40-detector CT scanner to time arterial phase imaging. Radiology 243:140–147CrossRefPubMed
20.
Zurück zum Zitat Sala M, Llovet JM, Vilana R, Bianchi L, Sole M, Ayuso C, Bru C, Bruix J (2004) Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma. Hepatology 40:1352–1360CrossRefPubMed Sala M, Llovet JM, Vilana R, Bianchi L, Sole M, Ayuso C, Bru C, Bruix J (2004) Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma. Hepatology 40:1352–1360CrossRefPubMed
21.
Zurück zum Zitat Barbara L, Benzi G, Gaiani S, Fusconi F, Zironi G, Siringo S, Rigamonti A, Barbara C, Grigioni W, Mazziotti A et al (1992) Natural history of small untreated hepatocellular carcinoma in cirrhosis: a multivariate analysis of prognostic factors of tumor growth rate and patient survival. Hepatology 16:132–137CrossRefPubMed Barbara L, Benzi G, Gaiani S, Fusconi F, Zironi G, Siringo S, Rigamonti A, Barbara C, Grigioni W, Mazziotti A et al (1992) Natural history of small untreated hepatocellular carcinoma in cirrhosis: a multivariate analysis of prognostic factors of tumor growth rate and patient survival. Hepatology 16:132–137CrossRefPubMed
22.
Zurück zum Zitat Kubota K, Ina H, Okada Y, Irie T (2003) Growth rate of primary single hepatocellular carcinoma: determining optimal screening interval with contrast enhanced computed tomography. Dig Dis Sci 48:581–586CrossRefPubMed Kubota K, Ina H, Okada Y, Irie T (2003) Growth rate of primary single hepatocellular carcinoma: determining optimal screening interval with contrast enhanced computed tomography. Dig Dis Sci 48:581–586CrossRefPubMed
23.
Zurück zum Zitat Okazaki N, Yoshino M, Yoshida T, Suzuki M, Moriyama N, Takayasu K, Makuuchi M, Yamazaki S, Hasegawa H, Noguchi M et al (1989) Evaluation of the prognosis for small hepatocellular carcinoma based on tumor volume doubling time. A preliminary report Cancer 63:2207–2210 Okazaki N, Yoshino M, Yoshida T, Suzuki M, Moriyama N, Takayasu K, Makuuchi M, Yamazaki S, Hasegawa H, Noguchi M et al (1989) Evaluation of the prognosis for small hepatocellular carcinoma based on tumor volume doubling time. A preliminary report Cancer 63:2207–2210
24.
Zurück zum Zitat Kim SH, Kim SH, Lee J, Kim MJ, Jeon YH, Park Y, Choi D, Lee WJ, Lim HK (2009) Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma. AJR Am J Roentgenol 192:1675–1681CrossRefPubMed Kim SH, Kim SH, Lee J, Kim MJ, Jeon YH, Park Y, Choi D, Lee WJ, Lim HK (2009) Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma. AJR Am J Roentgenol 192:1675–1681CrossRefPubMed
25.
Zurück zum Zitat Kim YK, Lee YH, Kwak HS, Kim CS, Han YM (2008) Clinical implication of small (<20 mm) enhancing hepatic nodules observed only during three-dimensional gadobenate dimeglumine-enhanced hepatic arterial-phase MRI of the hepatitis B virus-induced mild cirrhosis. Clin Imaging 32:453–459CrossRefPubMed Kim YK, Lee YH, Kwak HS, Kim CS, Han YM (2008) Clinical implication of small (<20 mm) enhancing hepatic nodules observed only during three-dimensional gadobenate dimeglumine-enhanced hepatic arterial-phase MRI of the hepatitis B virus-induced mild cirrhosis. Clin Imaging 32:453–459CrossRefPubMed
26.
Zurück zum Zitat Efremidis SC, Hytiroglou P, Matsui O (2007) Enhancement patterns and signal-intensity characteristics of small hepatocellular carcinoma in cirrhosis: pathologic basis and diagnostic challenges. Eur Radiol 17:2969–2982CrossRefPubMed Efremidis SC, Hytiroglou P, Matsui O (2007) Enhancement patterns and signal-intensity characteristics of small hepatocellular carcinoma in cirrhosis: pathologic basis and diagnostic challenges. Eur Radiol 17:2969–2982CrossRefPubMed
27.
Zurück zum Zitat Shinmura R, Matsui O, Kobayashi S, Terayama N, Sanada J, Ueda K, Gabata T, Kadoya M, Miyayama S (2005) Cirrhotic nodules: association between MR imaging signal intensity and intranodular blood supply. Radiology 237:512–519CrossRefPubMed Shinmura R, Matsui O, Kobayashi S, Terayama N, Sanada J, Ueda K, Gabata T, Kadoya M, Miyayama S (2005) Cirrhotic nodules: association between MR imaging signal intensity and intranodular blood supply. Radiology 237:512–519CrossRefPubMed
28.
Zurück zum Zitat Jeong YY, Mitchell DG, Kamishima T (2002) Small (<20 mm) enhancing hepatic nodules seen on arterial phase MR imaging of the cirrhotic liver: clinical implications. AJR Am J Roentgenol 178:1327–1334PubMed Jeong YY, Mitchell DG, Kamishima T (2002) Small (<20 mm) enhancing hepatic nodules seen on arterial phase MR imaging of the cirrhotic liver: clinical implications. AJR Am J Roentgenol 178:1327–1334PubMed
Metadaten
Titel
Outcomes of follow-up CT for small (5–10-mm) arterially enhancing nodules in the liver and risk factors for developing hepatocellular carcinoma in a surveillance population
verfasst von
Min Jung Park
Young-sun Kim
Won Jae Lee
Hyo K. Lim
Hyunchul Rhim
Jongmee Lee
Publikationsdatum
01.10.2010
Verlag
Springer-Verlag
Erschienen in
European Radiology / Ausgabe 10/2010
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-010-1810-y

Weitere Artikel der Ausgabe 10/2010

European Radiology 10/2010 Zur Ausgabe

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.